Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


'Benghazi'-Like Hearing Unlikely For Califf, But Expect Questions

This article was originally published in Scrip

Executive Summary

Robert Califf, President Barack Obama's nominee to lead the FDA, is expected to have a fairly easy time of it when he goes before a Senate panel at a confirmation hearing on Nov. 17 – so much so that he's still planning to speak later that day at the annual Conference on Clinical Cancer Research hosted by the Friends of Cancer Research (FOCR) and the Brookings Institution.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts